Esokalli Slimming microcrystalline patch

Manufacturer
Guangzhou Yixin Cross-border E-commerce Co., Ltd.
Effective date
2025-08-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:12:05

Label at a glance#

ProductEsokalli Slimming microcrystalline patch
Active ingredientRETATRUTIDE
Label structure11 sections

Indications and uses

To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch

Dosage and administration

For external use only.

Label contents#

Full prescribing information#

Active ingredient (in each patch)

COMPONENTS

Retatrutide 1.6 mg ……………………………. Weight management / blood sugar control

Purpose

OTC - PURPOSE SECTION

Weight loss aid
Improves blood sugar control (when used with diet and exercise)

Uses

INDICATIONS & USAGE SECTION

To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch

Warnings

WARNINGS SECTION

For external use only

Dosage and administration

DOSAGE & ADMINISTRATION SECTION

For external use only.

Do not use if you

OTC - DO NOT USE SECTION

have type 1 diabetes
need treatment for diabetic ketoacidosis
are pregnant or breastfeeding
are under 18 years of age

When using this product

OTC - WHEN USING SECTION

monitor blood glucose regularly

possible side effects include:
hypoglycemia

nausea, vomiting, or diarrhea

acute pancreatitis

complications of diabetic retinopathy

increased heart rate

hypersensitivity or allergic reactions

Stop use and ask a doctor if

OTC - STOP USE SECTION

• you develop severe abdominal pain (possible acute pancreatitis)

• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)

• persistent gastrointestinal problems occur

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, get medical help or contact a Poison Control Center right away.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11223344

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84778-078-01Esokalli Slimming microcrystalline patch1 U in 1 BOXPATCH11
84778-078-02Esokalli Slimming microcrystalline patch2 U in 1 BOXPATCH21
84778-078-03Esokalli Slimming microcrystalline patch4 U in 1 BOXPATCH41
84778-078-04Esokalli Slimming microcrystalline patch8 U in 1 BOXPATCH81

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84778-07884778-078-01, 84778-078-02, 84778-078-03, 84778-078-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3d18a8a9-68a5-1406-e063-6294a90a225c3d18a8a9-68a4-1406-e063-6294a90a225c2025-08-24WarningsExact identifier
spl id: 3d18a8a9-68a5-1406-e063-6294a90a225c
spl set id: 3d18a8a9-68a4-1406-e063-6294a90a225c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.